Categories: Business News

Analysis-AstraZeneca 'magic' faces rare test after trial failure, share slide

By Maggie Fick LONDON, July 24 (Reuters) – AstraZeneca's long-time CEO Pascal Soriot has rarely put a foot wrong. The company's shares have more that quadrupled in price…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: July 24, 2026 11:53:06 IST

By Maggie Fick LONDON, July 24 (Reuters) – AstraZeneca's long-time CEO Pascal Soriot has rarely put a foot wrong. The company's shares have more that quadrupled in price during his 14-year tenure,

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: July 24, 2026 11:53:06 IST

Recent Posts

Trump says Canada's Bombardier cannot sell in US unless it builds there

By Bhargav Acharya and Allison Lampert Sept 7 (Reuters) - President Donald Trump said on…

September 8, 2026

Red Star fans display tifo of convicted war criminal Mladic

VIDEO SHOWS:  VERTICAL VIDEO OF RED STAR BELGRADE FANS UNFURLING A TIFO FEATURING THE IMAGE…

September 8, 2026

MLB Tigers vs Twins Box Score

Tigers 5, Twins 4 Twins ab r h rbi bb so avg Keaschall RF 2…

September 8, 2026